LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…
2026 Kia Sportage Named 2025 TOP SAFETY PICK+ in 2025 IIHS Crash Test Ratings
2026 Kia SPORTAGE earns highest-tier 2025 TOP SAFETY PICK+ (TSP+) rating from…
Innovation in the Spotlight: Microvast at All-Energy Australia 2025
MELBOURNE, Australia, Oct. 30, 2025 /PRNewswire/ -- Microvast Holdings, Inc. (NASDAQ: MVST)…
IMG Partners with Riviera Travel to Provide Travel Insurance to U.S. Travelers
INDIANAPOLIS, Oct. 28, 2025 /PRNewswire/ -- IMG (International Medical Group) has announced…
ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors
SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation…
Cipla Health welcomes FSSAI’s new labelling rules for ‘ORS’, reinforces Prolyte ORS as the #AsliORS
MUMBAI, India, Oct. 24, 2025 /PRNewswire/ -- ProlyteORS, the flagship brand of…
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed…
LEPAS Hosts Its First Public Safety Test, Defining “Elegant Driving” Through Safety
WUHU, China, Oct. 22, 2025 /PRNewswire/ -- In the new era of…
Internet Watch Foundation and Public Interest Registry Extend Online Safety Initiative to Disrupt Criminal ‘brands’ Selling Child Sexual Abuse
A new sponsorship programme aims to help domain registrars 'disrupt' criminal businesses…
DFSK Celebrates 20 Years of Global Expansion with E5 PLUS, the First Overseas New Energy Strategic Model, Rolls Off the Production Line
CHONGQING, China, Oct. 22, 2025 /PRNewswire/ -- On October 22, 2025, at…